跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
Carvepen tablet 6.25 mg
Approved
THERAPEUTIC
Carvepen tablet 6.25 mg
Elpen Pharmaceutical Co.Inc
🇸🇬 Health Sciences Authority
Approval Date
Feb 25, 2008
Approval ID
9baa57c6e3c09dab
Company
Elpen Pharmaceutical Co.Inc
Type
Therapeutic
Approval Details
Approval Id
9baa57c6e3c09dab
Drug Name
Carvepen tablet 6.25 mg
Product Name
Carvepen tablet 6.25 mg
Approval Number
SIN13412P
Approval Date
2008-02-25
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C07AG02
Atc Item Name
carvedilol
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
Carvedilol
6.25 mg
CARVEDILOL
6.25 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 25, 2008
Approval ID
9baa57c6e3c09dab
Type
Therapeutic
Back to HSA Approvals
Carvepen tablet 6.25 mg - HSA Drug Approval Details